compound introduction
AN3199 is a PDE4 inhibitor with an IC 50 of 94.5 nM. AN3199 can be used for the research of inflammation-associated diseases such as asthma and chronic obstructive pulmonary disease (COPD) In Vitro AN3199 (compound 11) (1 h) disappears (98.0%) is mainly converts to corresponding acid (76.6) in mouse plasma. MCE has not independently confirmed the accuracy of these methods. They are for reference only. IC50& Target:PDE4 94.5 nM (IC 50 )
